Biotech

All Articles

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has opened up a $700 million R&ampD facility in the Boston Port, improving its own RNA an...

Boundless Biography makes 'modest' layoffs five months after $100M IPO

.Only five months after safeguarding a $one hundred thousand IPO, Vast Biography is actually already...

Halda's $126M will advance 'secure and get rid of' growth medications

.The first phases of oncology R&ampD may not be short of fascinating brand-new techniques, as well a...

Lykos 'disappointments' not revealing study infractions with publisher

.Psychopharmacology has actually pulled 3 articles concerning midstage medical test records examinin...

Analysts explore Avidity's DMD succeed, revealing nuances in information

.Avidity Biosciences pleased real estate investors along with period 1/2 information in Duchenne mus...

Actinogen's cortisol blocker stops working stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has overlooked the primary endpoint of a stage 2 study in clin...

Bivictrix chooses going exclusive only method to take ADC into facility

.Antibody-drug conjugates (ADCs) have gone to the center of several a billion-dollar biobuck licensi...

TPG tops up funds to $580M for assets throughout lifestyle scientific researches

.Resource supervisor TPG, which has actually sustained biotechs such as Sionna Rehabs and Santa Ana ...

Merck stops stage 3 TIGIT test in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT program has endured one more misfortune. Months after shuttering a stage 3 m...

After a difficult year, Exscientia folds up into Recursion

.After a year described by pipeline hairstyles, the variation of its chief executive officer and cut...